Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy

Circulation Journal

Volumn 78, Issue 1, 2014, Pages 151-158

  Uematsu, Manabu ^a   Nakamura, Takamitsu ^a   Sugamata, Wataru ^a   Kitta, Yoshinobu ^a   Fujioka, Daisuke ^a   Saito, Yukio ^a   Kawabata, Ken Ichi ^a   Obata, Jun Ei ^a   Watanabe, Yosuke ^a   Watanabe, Kazuhiro ^a   Kugiyama, Kiyotaka ^a  

^a YAMANASHI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Carotid arteries; Risk factors; Secondary prevention; Statin; Ultrasound

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; AGED; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PREDICTION; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SMOKING;

AGED; ANGINA, UNSTABLE; CAROTID STENOSIS; CHOLESTEROL, LDL; CHRONIC DISEASE; DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; RETROSPECTIVE STUDIES;

EID: 84891115299     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0783     Document Type: Article

References (28)

1. Rothwell PM, Villarga R, Gibson R, Donders RC, Warlow CP. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet 2000; 355: 19-24.
2. Libby P. Vascular biology of atherosclerosis: Overview and state of the art. Am J Cardiol 2003; 91: 3A-6A.
3. Kullo IJ, Malik AR. Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification. J Am Coll Cardiol 2007; 49: 1413-1426.
4. Watanabe K, Sugiyama S, Kugiyama K, Honda O, Fukushima H, Koga H, et al. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. J Am Coll Cardiol 2005; 46: 2022-2030.
5. Nakamura T, Kitta Y, Uematsu M, Sugamata W, Hirano M, Fujioka D, et al. Ultrasound assessment of brachial endothelial vasomotor function in addition to carotid plaque echolucency for predicting cardiovascular events in patients with coronary artery disease. Int J Cardiol 2013; 167: 555-560.
6. Hirano M, Nakamura T, Kitta Y, Sano K, Kodama Y, Kobayashi T, et al. Assessment of carotid plaque echolucency in addition to plaque size increases the predictive value of carotid ultrasound for coronary events in patients with coronary artery disease and mild carotid atherosclerosis. Atherosclerosis 2010; 211: 451-455.
7. Hirano M, Nakamura T, Kitta Y, Takishima I, Deyama J, Kobayashi T, et al. Short-term progression of maximum intima-media thickness of carotid plaque is associated with future coronary events in patients with coronary artery disease. Atherosclerosis 2011; 215: 507-512.
8. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009; 53: 323-330.
9. Grønholdt ML, Nordestgaard BG, Bentzon J, Wiebe BM, Zhou J, Falk E, et al. Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels. J Vasc Surg 2002; 35: 137-145.
10. Shepard RK, Miller JG, Wickline SA. Quantification of atherosclerotic composition in cholesterol-fed rabbits with 50-MHz acoustic microscopy. Arterioscler Thromb 1992; 12: 1227-1234.
11. Takiuchi S, Rakugi H, Honda K, Masuyama T, Hirata N, Ito H, et al. Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation 2000; 102: 766-770.
12. Waki H, Masuyama T, Mori H, Maeda T, Kitade K, Moriyasu K, et al. Ultrasonic tissue characterization of the atherosclerotic carotid artery: Histological correlates or carotid integrated backscatter. Circ J 2003; 67: 1013-1016.
13. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
14. Nakamura T, Obata JE, Hirano M, Kitta Y, Fujioka D, Saito Y, et al. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals. Atherosclerosis 2011; 218: 163-167.
15. Nakamura T, Obata JE, Kitta Y, Takano H, Kobayashi T, Fujioka D, et al. Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome. J Cardiovasc Pharmacol 2008; 51: 365-371.
16. de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML, et al. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 2008; 5: 280-288.
17. Takiuchi S, Kamide K, Miwa Y, Tomiyama M, Yoshii M, Matayoshi T, et al. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens 2004; 18: 17-23.
18. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172, discussion 207-212.
19. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: The role of reclassification measures. Ann Intern Med 2009; 150: 795-802.
20. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30: 11-21.
21. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: New mechanisms and clinical targets. Nat Med 2002; 8: 1257-1262.
22. Lafitte M, Pucheu Y, Latry K, Dijos M, Casassus E, Couffinhal T. Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndrome. Eur J Prev Cardiol 2013; 20: 283-290.
23. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake dB, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239.
24. Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, et al; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study. Circ J 2012; 76: 221-229.
25. Hirano M, Nakamura T, Obata JE, Fujioka D, Saito Y, Kawabata K, et al. Early improvement in carotid plaque echogenicity by acarbose in patients with acute coronary syndromes. Circ J 2012; 76: 1452-1460.
26. Ishizu T, Seo Y, Machino T, Kawamura R, Kimura T, Murakoshi N, et al. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy. Atherosclerosis 2011; 216: 120-124.
27. Nguyen-Thanh HT, Benzaquen BS. Screening for subclinical coronary artery disease measuring carotid intima media thickness. Am J Cardiol 2009; 104: 1383-1388.
28. Ogata T, Yasaka M, Wakugawa Y, Inoue T, Yasumori K, Kitazono T, et al. Long-term results of medical and surgical therapy for Japanese patients with moderate carotid stenosis. J Stroke Cerebrovasc Dis 2012; 21: 24-29.